Safety and Efficacy of Bromfenac Ophthalmic Solution ( Bromday ) Dosed Once Daily for Postoperative Ocular Inflammation and Pain

Purpose To evaluate the efficacy and ocular safety of bromfenac ophthalmic solution (bromfenac) 0.09% dosed once daily for the treatment of ocular inflammation and pain after cataract surgery with posterior chamber intraocular lens implantation. Design Randomized, double-masked, vehicle-controlled o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 2011-11, Vol.118 (11), p.2120-2127
Hauptverfasser:	Henderson, Bonnie A., MD, Gayton, Johnny L., MD, Chandler, Simon P., PhD, Gow, James A., BSc (Med), MD, Klier, Sharon M., MD, MPH, McNamara, Timothy R., PharmD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - adverse effects Benzophenones - administration & dosage Benzophenones - adverse effects Biological and medical sciences Bromobenzenes - administration & dosage Bromobenzenes - adverse effects Cataract Extraction Double-Blind Method Endpoint Determination Eye Pain - drug therapy Eye Pain - physiopathology Female Humans Inflammation - drug therapy Inflammation - physiopathology Lens Implantation, Intraocular Male Medical sciences Miscellaneous Ophthalmic Solutions - administration & dosage Ophthalmic Solutions - adverse effects Ophthalmology Pain, Postoperative - drug therapy Postoperative Complications Pseudophakia - physiopathology Treatment Outcome Uveitis, Anterior - drug therapy Uveitis, Anterior - physiopathology Visual Acuity - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!